Sativex, MS cannabis drug yet to take off
Sativex, MS cannabis drug yet to take off
GW Pharmaceuticals' pioneering cannabis drug is getting a mixed reception four months into its launch across Britain, its first European market.
A survey of primary care trusts today found several that were not recommending Savitex to multiple sclerosis patients, with many viewing it as “low priority”.... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1814
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post